Related Experiment Video

Updated: Oct 2, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Higher lipoprotein (a) levels in atherothrombotic than lacunar ischemic cerebrovascular disease

P Cerrato1, D Imperiale, P Fornengo

  • 1Department of Neuroscience, University of Turin, Torino, Italy. paolo_cerrato@yahoo.com

Neurology
|February 28, 2002
PubMed

Insights

Elevated Lipoprotein (a) levels are linked to atherothrombotic stroke, not lacunar stroke. This suggests Lipoprotein (a) promotes large vessel disease and thrombosis by hindering blood clot breakdown.

Area of Science:

  • Cardiovascular Science
  • Neurology
  • Lipid Metabolism

Background:

  • Ischemic cerebrovascular disease encompasses atherothrombotic and lacunar stroke subtypes.
  • Plasma lipid abnormalities are implicated in cerebrovascular disease pathogenesis.
  • Understanding subtype-specific lipid associations is crucial for targeted prevention and treatment.

Purpose of the Study:

  • To investigate the role of specific plasma lipid abnormalities in distinguishing between atherothrombotic and lacunar stroke subtypes.
  • To identify unique lipid markers associated with large versus small vessel ischemic cerebrovascular disease.

Main Methods:

  • A hospital-based cohort of 202 consecutive stroke patients was analyzed.
  • Lipid profiles, including Lipoprotein (a), were assessed for patients with atherothrombotic and lacunar stroke.
  • Statistical comparisons were made between lipid parameters across stroke subtypes.

Main Results:

  • Lipoprotein (a) was the sole lipid parameter significantly differing between atherothrombotic and lacunar stroke patients.
  • Patients with atherothrombotic stroke exhibited twofold higher Lipoprotein (a) levels compared to those with lacunar stroke.

Conclusions:

  • Lipoprotein (a) appears to play a distinct role in promoting large vessel atheromatosis, characteristic of atherothrombotic stroke.
  • Elevated Lipoprotein (a) may favor thrombosis on atheromatous plaques by inhibiting local fibrinolysis, contributing to atherothrombotic events.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...